INSULET CORP (NASDAQ:PODD) was identified by our screener as a strong growth stock with a favorable technical setup. The company, known for its innovative insulin delivery systems, combines solid fundamental growth metrics with a bullish price pattern. Below, we examine why PODD stands out.
Fundamental Strengths
Growth: PODD has demonstrated strong revenue and earnings expansion, with revenue growing 23.49% over the past year and EPS increasing by 79.24% annually over the last few years. Future EPS growth is projected at 20.57%.
Profitability: The company scores a 9/10 in profitability, with high margins (18.29% profit margin, 70.39% gross margin) that outperform most peers in the Health Care Equipment & Supplies industry.
Financial Health: While debt levels are somewhat elevated, liquidity remains strong, with a current ratio of 4.47 and a quick ratio of 3.63.
Technical Setup
Trend Strength: Both short-term and long-term trends are positive, with the stock trading near its 52-week high.
Bull Flag Pattern: PODD is forming a bull flag, a continuation pattern that often precedes further upside. Resistance sits near $325, with support around $320.
Relative Strength: The stock outperforms 95% of its industry peers and 95% of the broader market over the past year.
This is not investment advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.